Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?

• Luuk Gras ,

  * E-mail: l.a.gras@amc.uva.nl

  Affiliation Stichting HIV Monitoring, Amsterdam, The Netherlands

  ⨯
• Ronald B. Geskus,

  Affiliations Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands, Cluster of Infectious Diseases, Department of Research, Public Health Service of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Suzanne Jurriaans,

  Affiliation Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Margreet Bakker,

  Affiliation Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Ard van Sighem,

  Affiliation Stichting HIV Monitoring, Amsterdam, The Netherlands

  ⨯
• Daniela Bezemer,

  Affiliation Stichting HIV Monitoring, Amsterdam, The Netherlands

  ⨯
• Christophe Fraser,

  Affiliation Department of Infectious Disease Epidemiology, Imperial College School of Medicine, London, United Kingdom

  ⨯
• Jan M. Prins,

  Affiliation Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, and Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Ben Berkhout,

  Affiliation Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Frank de Wolf1,4 for the ATHENA national observational cohort

  ¶Membership of the ATHENA national observational cohort is provided in the Acknowledgments

  ⨯